Rapamycin Suppresses Immune System, Raises Infection Risk
D
Dr. Ben Bikman's podcast episode on September 12, 2024
“Rapamycin will suppress the immune system leading to an increased risk of infection.”
Story of claim
Rapamycin is used post-organ transplant to prevent rejection but increases infection risk due to immune suppression. Dr. Bikman highlights its metabolic side effects, including elevated triglycerides.
- Goal: To prevent organ rejection in transplant patients by suppressing the immune system.
- Proof: Rapamycin effectively suppresses the immune system, preventing organ rejection but increasing infection risk as claimed by Dr. Bikman.
- Nuances:
- Long-term use increases infection risk due to immune suppression.
- Rapamycin can raise triglycerides, increasing heart disease risk.
- Impact on Life: Patients may experience higher infection rates, affecting daily activities and overall health.
Investments
- Price: Cost varies based on prescription and insurance coverage.
- Time: Ongoing use post-transplant
- Effort: Regular monitoring of infection signs and triglyceride levels
Risks
Increased infection risk and metabolic disturbances like high triglycerides.
Alternatives
- Alternative immunosuppressants may be considered by doctors.
Get Started 🚀
- Consult with your healthcare provider about rapamycin post-transplant.
- Monitor triglyceride levels regularly.
- Watch for signs of infection and report them to your doctor.
Brogevity AI can make mistakes. Check important info.